{"disease":{"id":"seizure-disorders","name":"seizure disorders"},"drugs":{"marketed":[{"drug_id":"ganaxolone","indication_name":"Seizures associated with CDKL5 deficiency disorders","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ztalmy","generic_name":"GANAXOLONE","company_name":"Marinus","drug_phase":"marketed","molecular_target":"GABA A receptor alpha-2/beta-1/gamma-2","drug_class":"Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]","quality_score":48,"revenue":null,"mechanism":"Ztalmy works by enhancing the activity of the GABA A receptor, a key player in regulating the activity of neurons in the brain."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07274410","title":"Clinical Profile And Outcomes Of Neonatal Convulsions In The Neonatal Intensive Care Unit At Assiut University Children's Hospital","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":139,"lead_sponsor_name":"Assiut University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}